Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Proceedings of the National Academy of Sciences of the United States of America
|
June 29, 2026
Junctophilin-2-orchestrated calcium signalosome regulates brown adipocyte thermogenesis and energy metabolism
Biyi Chen, Jinxi Wang, Qingwen Qian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Leora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Nature
|
November 11, 2021
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao, Yonina R Murciano-Goroff, Jenny Y Xue, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Medicine
|
April 20, 2022
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
Bob T Li, Bobby Daly, Mary Gospodarowicz, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
Nature Medicine
|
November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Justin Jee, Emily S Lebow, Randy Yeh, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Proceedings of the National Academy of Sciences of the United States of America
|
June 29, 2026
Junctophilin-2-orchestrated calcium signalosome regulates brown adipocyte thermogenesis and energy metabolism
Biyi Chen, Jinxi Wang, Qingwen Qian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Leora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Nature
|
November 11, 2021
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao, Yonina R Murciano-Goroff, Jenny Y Xue, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Medicine
|
April 20, 2022
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
Bob T Li, Bobby Daly, Mary Gospodarowicz, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
Nature Medicine
|
November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Justin Jee, Emily S Lebow, Randy Yeh, et al.
Page
of 9